Tobii Dynavox AB (publ) (TDVXF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Tobii Dynavox AB (publ) (TDVXF) trades at $7.68 with AI Score 56/100 (Grade B). Dynavox Group AB (publ) develops and sells assistive technology products for individuals with communication impairments. Market cap: $810.64M, Sector: Healthcare.
Last analyzed: Mar 15, 2026Analyst Coverage for TDVXF: TDVXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TDVXF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
TDVXF: 2/4 perspectives are bearish. Dominant signal: Izzy Englander bearish.
Tobii Dynavox AB (publ) (TDVXF) Healthcare & Pipeline Overview
Dynavox Group AB (publ) is a global provider of augmentative and alternative communication (AAC) solutions for individuals with communication disabilities. The company offers custom hardware, software, and support services, distinguishing itself through comprehensive solutions and a wide geographic reach in the medical instruments and supplies sector.
What Is the Investment Thesis for TDVXF?
Dynavox Group AB presents a notable research candidate within the assistive technology sector. The company's focus on augmentative and alternative communication (AAC) solutions addresses a critical need for individuals with communication impairments. With a gross margin of 68.4% and an ROE of 31.4%, Dynavox demonstrates strong profitability and efficient capital utilization. Growth catalysts include expanding its geographic reach, developing new AAC technologies, and increasing market penetration. However, the company's high debt-to-equity ratio of 183.39 and negative free cash flow pose potential risks. Investors should monitor the company's ability to manage its debt and improve cash flow generation. The company's beta of 1.00 indicates market average volatility.
Based on FMP financials and quantitative analysis
TDVXF Key Highlights
- Market capitalization of $0.92 billion, reflecting the company's current valuation in the market.
- Gross margin of 68.4%, indicating strong pricing power and efficient cost management in its operations.
- Return on Equity (ROE) of 31.4%, showcasing the company's ability to generate profits from shareholders' equity.
- Debt-to-Equity ratio of 183.39, suggesting a relatively high level of financial leverage which could pose risks.
- Operations across multiple countries, including Sweden, the United States, Germany, and China, providing geographic diversification.
Who Are TDVXF's Competitors?
TDVXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NYXH Nyxoah S.A. | $1.41 | -5.54% | $55.75M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $20.97 | +4.14% | $1.22B | 67 |
| ZTEK Zentek Ltd. | $0.45 | +3.11% | $48.80M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| HOCPY HOYA Corporation | $166.27 | +0.93% | $55.62B | 56 |
| ISRG Intuitive Surgical, Inc. | $406.74 | -1.49% | $144.05B | 56 |
| ANSLY Ansell Limited | $74.38 | +0.00% | $2.63B | 56 |
| ANSLF Ansell Limited | $19.59 | +0.00% | $2.77B | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TDVXF's Key Strengths?
- Comprehensive AAC solutions including hardware, software, and support.
- Global presence with operations in multiple countries.
- Strong brand reputation and customer loyalty.
- High gross margin of 68.4%.
What Are TDVXF's Weaknesses?
- High debt-to-equity ratio of 183.39.
- Negative free cash flow.
- Dependence on specific customer segments.
- OTC market listing may limit investor access.
What Could Drive TDVXF Stock Higher?
- Potential regulatory approvals for new AAC devices in key markets.
- Expansion of telehealth offerings to reach more customers remotely.
- Strategic partnerships with healthcare providers to integrate AAC solutions into patient care programs.
What Are the Key Risks for TDVXF?
- Changes in healthcare regulations and reimbursement policies could affect revenue.
- Competition from other AAC solution providers could erode market share.
- High debt-to-equity ratio poses financial risk.
- Negative free cash flow may limit investment in growth initiatives.
What Are the Growth Opportunities for TDVXF?
- Expansion into Emerging Markets: Dynavox has the opportunity to expand its presence in emerging markets, such as Asia and Latin America, where there is a growing demand for assistive technology. These regions have a large population of individuals with communication impairments and limited access to AAC solutions. By entering these markets, Dynavox can increase its revenue and market share. This expansion could contribute an additional 10-15% to revenue growth over the next 3-5 years, with a potential market size of $500 million.
- Development of New AAC Technologies: Dynavox can invest in the development of new AAC technologies, such as AI-powered communication devices and virtual reality-based therapy solutions. These innovative technologies can improve the effectiveness and accessibility of AAC solutions, attracting new customers and increasing customer retention. The market for AI in healthcare is projected to reach $34 billion by 2025, offering a significant growth opportunity for Dynavox.
- Strategic Partnerships with Healthcare Providers: Dynavox can form strategic partnerships with healthcare providers, such as hospitals, clinics, and rehabilitation centers, to integrate its AAC solutions into their patient care programs. These partnerships can provide Dynavox with access to a larger customer base and increase the adoption of its products. Collaborations with major healthcare networks could boost sales by 15-20% within the next two years.
- Increased Focus on Telehealth Solutions: With the growing adoption of telehealth, Dynavox can expand its telehealth offerings, providing remote AAC therapy and support services to customers. This can improve access to care for individuals in remote areas and reduce the cost of therapy. The telehealth market is expected to reach $175 billion by 2026, presenting a significant growth opportunity for Dynavox.
- Enhanced Customer Support and Training Programs: Dynavox can enhance its customer support and training programs to improve customer satisfaction and retention. This includes providing online resources, webinars, and in-person training sessions for customers and their caregivers. By offering comprehensive support, Dynavox can differentiate itself from competitors and build long-term customer relationships. Improved customer retention could increase recurring revenue by 10% annually.
What Opportunities Does TDVXF Have?
- Expansion into emerging markets.
- Development of new AAC technologies.
- Strategic partnerships with healthcare providers.
- Increased focus on telehealth solutions.
What Threats Does TDVXF Face?
- Competition from other AAC solution providers.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns affecting customer spending.
- Technological obsolescence.
What Are TDVXF's Competitive Advantages?
- Proprietary AAC technology and software solutions.
- Strong brand reputation and customer loyalty.
- Extensive distribution network across multiple countries.
- Customized solutions tailored to individual needs.
- Comprehensive support and training programs.
What Does TDVXF Do?
Dynavox Group AB (publ), formerly known as Tobii Dynavox AB, was incorporated in 2012 and is headquartered in Stockholm, Sweden. The company focuses on developing and selling assistive technology products designed for individuals with impaired communication skills. Dynavox offers augmentative and alternative communication (AAC) solutions, which enable people with disabilities such as cerebral palsy, ALS, autism, and spinal cord injury to communicate independently. These solutions encompass language, software, hardware, funding assistance, support, and training. The company's AAC solutions are custom designed to meet the specific needs of each user, ensuring effective communication. Dynavox operates across a wide geographic area, including Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand. This broad international presence allows Dynavox to serve a diverse customer base and adapt its offerings to different cultural and regulatory environments. The company rebranded from Tobii Dynavox AB in July 2024, marking a new chapter in its corporate evolution and strategic focus on AAC solutions.
What Products and Services Does TDVXF Offer?
- Develops augmentative and alternative communication (AAC) solutions.
- Offers custom-designed communication devices for individuals with disabilities.
- Provides software solutions to aid in communication.
- Manufactures hardware components for AAC devices.
- Offers funding support and guidance to customers.
- Provides training and support for users and caregivers.
- Operates in multiple countries, including the US, Europe, and Asia.
How Does TDVXF Make Money?
- Sells AAC devices and software directly to customers and through distributors.
- Provides ongoing support and training services for a fee.
- Offers customized solutions tailored to individual needs.
- Generates revenue through hardware sales, software licenses, and service contracts.
What Industry Does TDVXF Operate In?
Dynavox Group AB operates in the medical instruments and supplies industry, specifically within the assistive technology market. This market is driven by the increasing prevalence of communication disorders and the growing demand for AAC solutions. The competitive landscape includes companies offering similar assistive technology products and services. Dynavox differentiates itself through its comprehensive AAC solutions, which include software, hardware, and support. The industry is expected to grow as technology advances and awareness of AAC solutions increases.
Who Are TDVXF's Key Customers?
- Individuals with cerebral palsy, ALS, autism, and spinal cord injury.
- Hospitals and rehabilitation centers.
- Schools and educational institutions.
- Caregivers and family members of individuals with communication impairments.
TDVXF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
TDVXF Latest News
-
Uncovering YIT Oyj And Two More European Stocks That May Be Trading Below Estimated Value
Yahoo! Finance: TDVXF News · May 26, 2026
-
Dynavox Group AB (publ) (TDVXF) Q1 2026 Earnings Call Transcript
seekingalpha.com · Apr 24, 2026
TDVXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TDVXF.
Price Targets
Wall Street price target analysis for TDVXF.
TDVXF MoonshotScore
What does this score mean?
The MoonshotScore rates TDVXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
TDVXF OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the lack of stringent regulatory oversight and reporting standards compared to listed companies. This tier is often populated by speculative ventures or companies with financial difficulties.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volumes can lead to price volatility.
- Wider bid-ask spreads can increase transaction costs.
- Less regulatory oversight compared to listed exchanges.
- Potential for delisting or trading suspensions.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's business model and growth prospects.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Established operations in multiple countries.
- Focus on assistive technology with a clear social mission.
- History of developing and selling AAC solutions.
- Positive customer reviews and testimonials.
- Partnerships with healthcare providers or research institutions (if any).
Common Questions About TDVXF (Healthcare)
What does Dynavox Group AB (publ) do?
Dynavox Group AB (publ) specializes in developing and selling augmentative and alternative communication (AAC) solutions for individuals with communication impairments. These solutions include custom-designed hardware and software that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate independently. Dynavox operates globally, providing comprehensive support and training services to ensure effective use of its AAC solutions, thereby improving the quality of life for its users.
What do analysts say about TDVXF stock?
As of 2026-03-15, formal analyst ratings for TDVXF may be limited due to its OTC listing. However, key valuation metrics include a market capitalization of $0.92 billion, a gross margin of 68.4%, and an ROE of 31.4%. Growth considerations center on the company's ability to expand into new markets, develop innovative AAC technologies, and manage its debt. Investors should conduct their own due diligence and consider the risks associated with OTC stocks before investing.
What are the main risks for TDVXF?
The main risks for Dynavox Group AB (publ) include its high debt-to-equity ratio of 183.39, which could constrain its financial flexibility. Negative free cash flow poses challenges for funding growth initiatives. Competition from other AAC solution providers and potential changes in healthcare regulations could also affect revenue. As an OTC-listed stock, TDVXF faces additional risks related to liquidity, price volatility, and limited financial disclosure.
What are the key factors to evaluate for TDVXF?
Tobii Dynavox AB (publ) (TDVXF) holds an AI score of 56/100 (moderate). P/E: 41.8x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does TDVXF data refresh on this page?
TDVXF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven TDVXF's recent stock price performance?
Tobii Dynavox AB (publ) (TDVXF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive AAC solutions including hardware, software, and support. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TDVXF overvalued or undervalued right now?
Tobii Dynavox AB (publ) (TDVXF) trades at 41.8x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying TDVXF?
Before investing in Tobii Dynavox AB (publ) (TDVXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.
- Analyst ratings may not be readily available for OTC stocks.